| Ki | - | 
                
                    | EC50 |  | 
                
                    | IC50 | 0.62±0.01μM(RatAChE),  62.0±0.72μM( RatBCHE),  0.25±0.03μM(HuAChE) | 
                
                    | Inhibition | 62.2±1.8%( human AChE-induced Aβ1-40 aggregation),  85.7±2.5%( Cu2+-induced Aβ1-42 aggregation ),  69.1±1.8%( self-induced Aβ1-42 aggregation) | 
                
                    | Toxicity |  | 
                
                    | ROS(reactive oxygen species) | 0.84 | 
                
                    | Metal Chelating | Cu2+ | 
                
                    | BBB(blood-brain barrier) |  | 
                
                    | Target Protein | Acetylcholinesterase (AChE) | 
                
                    | Effects | Demonstrated significant metal chelating properties,  moderate acetylcholinesterase(AChE) inhibitory and anti-oxidative activity,  and excellent inhibitory effects on self-induced Aβ1-42 aggregation,  Cu2+-induced Ab1-42 aggregation,  human AChE-induced Aβ1-40 aggregation and disassembled Cu2+-induced aggregation of the well-structured Aβ1-42 fibrils. | 
                
                    | Research Models | In PC12 cell ,  in SH-SY5Y cell,  in mice | 
                
                    | Ref. Link |  |